期刊文献+

奥沙利铂对大鼠后根神经节及神经生长因子表达的影响 被引量:20

Expression of nerve growth factor in dorsal root ganglia and its relation to oxaliplatin treatment in rats
暂未订购
导出
摘要 目的探讨神经生长因子的表达(nerve growth factor, NGF)在奥沙利铂(草酸铂)应用期间的变化规律以及与其对周围神经系统毒性的靶器官后根神经节(dorsal root ganglia,DRG)的神经元形态改变的相关性.方法采用光镜技术和免疫组化染色法观察DRG在不同时间及不同剂量时的形态改变以及DRG内NGF的表达,并以图像分析仪进行分析.结果 DRG内NGF表达下调与神经元的形态改变均在用药后24~48小时最为显著,5周后基本恢复,且均表现为药物剂量依赖性.结论草酸铂应用期间,DRG内NGF表达下调具有药物剂量依赖性及可恢复性的特点,且与DRG内感觉神经元核仁的形态改变呈正相关(r2=0.9929,P<0.0001),提示NGF表达的变化与草酸铂的周围神经系统毒性有关,为外源性NGF可能缓解其周围神经毒性提供依据. Objective To investigate the expression of nerve growth factor(NGF) in dorsal root ganglia(DRG) of rats during oxaliplatin treatment and its relation to the neurotoxicity of oxaliplatin. Methods Left L4-5 DRG sensory neurons of rats were examined under the light microscopy after oxaliplatin treatment. The expression of NGF in DRG was detected by immunohistochemistry. Morphological changes of DRG and the expression of NGF were analyzed by Digital Medical Image Analysis System. Results The down-regulation of NGF expression and morphological changes of DRG were evident at 24-48 h after oxaliplatin treatment and completely recovered in 5th week. The changes of NGF expression were correlated with the morphological damage of DRG sensory neurons (r= 0. 9929, P〈0. 0001). Both presented a dose-dependent manner. Conclusion The down-regulation of NGF expression may play an important role in neurotoxicity induced by oxaliplatin.
出处 《实用肿瘤杂志》 CAS 2005年第4期293-296,共4页 Journal of Practical Oncology
关键词 铂化合物/投药和剂量 草酸盐类/投药和剂量 神经生长因子 免疫组织化学 基因表达 platinum compounds/administration & dosage oxalates/administration & dosage nerve growth factors immunohistochemistry gene expression
  • 相关文献

参考文献8

  • 1McKeage MJ, Hsu T, Screnci D, et al. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs [J]. Br J Cancer, 2001,85(8): 1219-1225.
  • 2Cavaletti G, Pezzoni G, Pisano C, et al. Cisplatininduced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor [J]. Neurosci Lett, 2002,322(2):103-106.
  • 3Cavaletti G, Petruccioli MG, Marmiroli P, et al.Circulating nerve growth factor level changes during oxallplatin treatment-induced neurotoxiclty in the rat[J]. Anticancer Res, 2002,22(6C) : 4199- 4204.
  • 4De Santis S, Pace A, Bove L, et al. Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor [J]. Clin Cancer Res, 2000,6(1):90-95.
  • 5Jamieson SM, Liu J, Hsu T, et al. Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity [J]. Br J Cancer,2003,88(12):1942-1947.
  • 6Delaloge S, Laadem A, Taamma A, et al. Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer [J]. Am J Clin Oncol, 2000,23(6):569-574.
  • 7Aloe L, Mannl L, Properzi F, et al. Evidence that growth factor promotes the recovery of peripheral neuropathy induced in mice by clsplatin:behavioral, structural and biochemical analysis [J].Auton Neurosci, 2000,86(1-2):84-93.
  • 8Russell JW, Windebank AJ, McNiven MA, et al.Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity [J]. Brain Res,1995,676(2):258-267.

同被引文献187

引证文献20

二级引证文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部